IRWD- Ironwood Pharmaceuticals, Inc.

Name: Ironwood Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Ironwood Pharmaceuticals, Inc. (IRWD) has 13 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. IRWD is classified in the Pharmaceuticals industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	McCourt Thomas A	1.90M	$7.84M	-
Dir	Currie Mark G	676.9K	$2.80M	-
VP	Shetzline Michael	658.0K	$2.72M	-
Other	John Minardo	500.5K	$2.07M	-
Other	Silver Ronald	416.6K	$1.72M	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 12, 2024	McCourt Thomas A66	Chief Executive Officer	Sell	177,164	$15.24	$2,699,979.36	-17.5%	-56.5%	-87.8%
Dec 14, 2023	Kessler Marla L	Director	Sell	9,926	$11.19	$111,071.94	-9.3%	-24.5%	-69.2%
Nov 20, 2023	Davis Andrew73	SVP, Chief Business Officer	Sell	3,287	$9.69	$31,851.03	-1.5%	+55.9%	-59.9%
Sep 15, 2023	Emany Sravan Kumar47	SVP, Chief Financial Officer	Buy	36,072	$8.32	$300,119.04	+23.6%	+37.3%	-45.2%
Aug 14, 2023	Silver Ronald68	Principal Accounting Officer	Sell	1,976	$10.04	$19,839.04	-1.5%	-6.3%	-55.2%
Aug 14, 2023	John Minardo69	Chief Legal Officer	Sell	7,045	$10.04	$70,731.80	-3.5%	-6.3%	-55.2%
May 30, 2023	McCourt Thomas A66	Chief Executive Officer	Sell	26,632	$10.70	$284,962.40	-3.4%	-15.3%	-43.9%
May 22, 2023	Davis Andrew73	SVP, Chief Business Officer	Sell	6,305	$10.12	$63,806.60	-2.8%	-10.4%	-37.5%
May 22, 2023	McCourt Thomas A66	Chief Executive Officer	Sell	36,000	$10.12	$364,320.00	-4.4%	-10.4%	-37.5%
May 22, 2023	Shetzline Michael67	CMO,SVP,Head-res&Drug	Sell	10,324	$10.12	$104,478.88	-3.1%	-10.4%	-37.5%

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC